LAMA1
Basic information
Region (hg38): 18:6941742-7117797
Previous symbols: [ "LAMA" ]
Links
Phenotypes
GenCC
Source:
- ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome (Definitive), mode of inheritance: AR
- ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome (Strong), mode of inheritance: AR
- ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Poretti-Boltshauser syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 25105227 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (34 variants)
- Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome (26 variants)
- LAMA1-related disorder (2 variants)
- Inborn genetic diseases (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAMA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 260 | 40 | 304 | |||
missense | 547 | 33 | 27 | 609 | ||
nonsense | 23 | 11 | 35 | |||
start loss | 0 | |||||
frameshift | 27 | 12 | 39 | |||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 12 | |||||
splice region | 2 | 2 | 26 | 24 | 6 | 60 |
non coding | 104 | 29 | 140 | |||
Total | 55 | 32 | 566 | 397 | 96 |
Highest pathogenic variant AF is 0.0000986
Variants in LAMA1
This is a list of pathogenic ClinVar variants found in the LAMA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-6942087-C-T | Uncertain significance (May 17, 2021) | |||
18-6942109-GA-G | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | Likely pathogenic (Mar 12, 2018) | ||
18-6942119-T-C | Inborn genetic diseases | Uncertain significance (Dec 13, 2023) | ||
18-6942126-C-T | Uncertain significance (Aug 09, 2022) | |||
18-6942130-C-T | Likely benign (Aug 15, 2022) | |||
18-6942141-A-G | Uncertain significance (Aug 04, 2023) | |||
18-6942147-A-G | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | Uncertain significance (May 06, 2021) | ||
18-6942149-G-C | Uncertain significance (Dec 16, 2021) | |||
18-6942161-G-A | Uncertain significance (Apr 06, 2022) | |||
18-6942184-C-T | Likely benign (Mar 08, 2023) | |||
18-6942196-G-A | Likely benign (May 04, 2023) | |||
18-6942197-C-T | Uncertain significance (Oct 03, 2023) | |||
18-6942202-C-T | Likely benign (May 03, 2022) | |||
18-6942215-C-T | Uncertain significance (Jun 05, 2022) | |||
18-6942216-G-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
18-6942239-G-T | Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome | Uncertain significance (Feb 06, 2020) | ||
18-6943171-C-T | Uncertain significance (Mar 29, 2022) | |||
18-6943172-G-A | Benign (Apr 29, 2023) | |||
18-6943176-A-G | not specified • Inborn genetic diseases | Benign/Likely benign (Jan 08, 2024) | ||
18-6943229-C-T | Benign (Dec 13, 2022) | |||
18-6943249-C-T | Uncertain significance (Oct 03, 2023) | |||
18-6943250-G-A | Likely benign (Nov 01, 2023) | |||
18-6943251-C-T | Inborn genetic diseases | Uncertain significance (Jan 25, 2023) | ||
18-6943256-T-C | Likely benign (Apr 01, 2023) | |||
18-6943258-C-T | Inborn genetic diseases | Uncertain significance (Apr 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LAMA1 | protein_coding | protein_coding | ENST00000389658 | 63 | 176071 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.22e-32 | 1.00 | 125502 | 1 | 245 | 125748 | 0.000979 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.136 | 1731 | 1.72e+3 | 1.01 | 0.000104 | 20117 |
Missense in Polyphen | 611 | 651.6 | 0.9377 | 7833 | ||
Synonymous | -1.31 | 735 | 691 | 1.06 | 0.0000480 | 5924 |
Loss of Function | 5.54 | 78 | 152 | 0.515 | 0.00000780 | 1902 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00150 | 0.00149 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.00125 | 0.00125 |
Finnish | 0.000190 | 0.000185 |
European (Non-Finnish) | 0.00129 | 0.00128 |
Middle Eastern | 0.00125 | 0.00125 |
South Asian | 0.000821 | 0.000817 |
Other | 0.00131 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.;
- Disease
- DISEASE: Poretti-Boltshauser syndrome (PTBHS) [MIM:615960]: An autosomal recessive disorder characterized by cerebellar dysplasia, cerebellar vermis atrophy, cerebellar cysts in most patients, high myopia, variable retinal dystrophy, and eye movement abnormalities including strabismus, ocular apraxia, nystagmus. Affected individuals have ataxia, delayed motor development, language impairment, and intellectual disability with variable severity. {ECO:0000269|PubMed:25105227}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Alpha 6 Beta 4 signaling pathway;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Developmental Biology;Signal Transduction;prion pathway;Laminin interactions;Extracellular matrix organization;agrin in postsynaptic differentiation;a6b1 and a6b4 Integrin signaling;L1CAM interactions;Non-integrin membrane-ECM interactions;Axon guidance;ECM proteoglycans;MET activates PTK2 signaling;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Glypican 1 network;Beta1 integrin cell surface interactions;Alpha6 beta4 integrin-ligand interactions;Syndecan-4-mediated signaling events;Syndecan-2-mediated signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.876
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.22
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- Y
- hipred_score
- 0.577
- ghis
- 0.461
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.551
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Lama1
- Phenotype
- embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- lama1
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- poorly differentiated
Gene ontology
- Biological process
- morphogenesis of an epithelial sheet;protein phosphorylation;cell adhesion;cell surface receptor signaling pathway;regulation of cell adhesion;extracellular matrix organization;regulation of cell migration;neuron projection development;establishment of epithelial cell apical/basal polarity;regulation of embryonic development;epithelial tube branching involved in lung morphogenesis;branching involved in salivary gland morphogenesis;retinal blood vessel morphogenesis
- Cellular component
- extracellular region;basement membrane;laminin-1 complex;laminin-3 complex;extracellular space;cell-cell junction;membrane;extracellular matrix;collagen-containing extracellular matrix
- Molecular function
- signaling receptor binding;extracellular matrix structural constituent;protein binding;protein C-terminus binding;glycosphingolipid binding